Phase 3 Gene Therapy for Painful Diabetic Neuropathy

Clinical trial NCT02427464 · COMPLETED

Trial details

NCT number: NCT02427464
Sponsor: Helixmith Co., Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Painful Diabetic Neuropathy Diabetic Neuropathy, Painful

Start date: 2016-04-01
Primary completion: 2019-04-01
Enrollment: 507

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.